• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Sedana Medical

8.15 SEK

+0.37 %

Less than 1K followers

SEDANA

NASDAQ Stockholm

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
+0.37 %
-16.75 %
-4.45 %
-20.72 %
-21.63 %
-19.94 %
-70.41 %
-89.08 %
+36.97 %

Sedana Medical operates in the medical technology industry and focuses on the development and manufacture of systems for inhalation anesthesia. The company's products are aimed at healthcare institutions and anesthesiologists. The business is global with a main presence in Europe, North America and Asia. Sedana Medical was founded in 2005 and is headquartered in Danderyd, Sweden.

Read more
Market cap
809.6M SEK
Turnover
569.57K SEK
Revenue
200.23M
EBIT %
-16.06 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
ShowingAll content types

Forum discussions
Sedana Medical AB doesn’t have its own thread, although I believe it’s on many investors’ radar or even in their portfolios, at least if they are focused on medtech stocks. The company was founded in 2005 and its headquarters are in Stockholm. The company specializes in sedation ...
8/3/2025, 1:08 PM
by Hawkmountdiver
7
The figures can be found in this latest interim report. Q2 / 2025 was a slightly weaker-than-expected quarter, which at least for a moment scared investors. storage.mfn.se sedana-medical-interim-report-q225.pdf
8/3/2025, 8:42 PM
by Hawkmountdiver
0
Read more on our forum
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
17.7
2026

Interim report Q2'26

22.10
2026

Interim report Q3'26

Regulatory press release6/17/2026, 6:00 AM

Mikael Haag takes office as new CFO of Sedana Medical

Sedana Medical
Press release6/17/2026, 5:30 AM

Sedana Medical submits New Drug Application to the U.S. FDA for inhaled sedation in the ICU

Sedana Medical
Regulatory press release5/27/2026, 3:30 PM

Report from Sedana Medical AB’s annual general meeting on 27 May 2026

Sedana Medical

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Regulatory press release4/24/2026, 12:00 PM

Notice of Annual General Meeting in Sedana Medical

Sedana Medical
Regulatory press release4/23/2026, 5:00 AM

Sedana Medical AB’s Interim report January-March 2026

Sedana Medical
Regulatory press release4/14/2026, 4:00 PM

Sedana Medical publishes its Annual Report for 2025

Sedana Medical
Press release4/10/2026, 6:00 AM

Invitation to presentation of Sedana Medical’s interim report for the first quarter 2026

Sedana Medical
Press release3/13/2026, 7:00 AM

Sedana Medical reports first patient treated in Early Access Program in the U.S.

Sedana Medical
Regulatory press release2/12/2026, 6:00 AM

Sedana Medical AB’s Year-end report 2025

Sedana Medical
Press release1/29/2026, 7:00 AM

Invitation to presentation of Sedana Medical’s interim report for the fourth quarter 2025

Sedana Medical
Regulatory press release1/27/2026, 7:00 AM

Sedana Medical appoints Mikael Haag as Chief Financial Officer (CFO)

Sedana Medical
Regulatory press release12/19/2025, 4:30 PM

CFO Johan Spetz to leave Sedana Medical

Sedana Medical
Regulatory press release11/24/2025, 7:00 AM

Sedana Medical reports positive pre-NDA meeting with FDA

Sedana Medical
Regulatory press release10/24/2025, 5:00 AM

Sedana Medical AB’s Interim report January-September 2025

Sedana Medical
Regulatory press release10/16/2025, 4:00 PM

Sedana Medical’s Nomination Committee for the 2026 Annual General Meeting

Sedana Medical
Press release10/10/2025, 6:00 AM

Invitation to presentation of Sedana Medical’s interim report for the third quarter 2025

Sedana Medical
Regulatory press release7/18/2025, 5:00 AM

Sedana Medical AB’s Interim report January-June 2025

Sedana Medical
Press release7/16/2025, 6:00 AM

Sedana Medical's paediatric study published in The Lancet

Sedana Medical
Press release7/4/2025, 6:00 AM

Invitation to presentation of Sedana Medical’s interim report for the second quarter 2025

Sedana Medical
Press release6/10/2025, 6:00 AM

Both of Sedana Medical´s pivotal US studies meet first key secondary endpoint

Sedana Medical